Skip to main content
SpringerLink
Log in

Brennpunkt Infektiologie

  • Brennpunkt Infektiologie
  • Published:
Wiener klinisches Magazin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Pagano L et al. (2006). The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91: 1068–75

    PubMed  Google Scholar 

  2. Neofytos D et al. (2009). Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48: 265–73

    Article  CAS  PubMed  Google Scholar 

  3. Böhme A et al. (2009). Treatment of invasive fungal infections in cancer patients - recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 88: 97–110

    Article  PubMed  Google Scholar 

  4. Liu CY et al. (2009). Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome. J Infect 58: 154–60

    Article  CAS  PubMed  Google Scholar 

  5. Herbrecht R et al. (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408–15

    Article  CAS  PubMed  Google Scholar 

  6. Raad II et al. (2008) Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia;22:496–503

    Google Scholar 

  7. Cornely OA et al. (2009). Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the infectious diseases working party of the german society for haematology and oncology. Haematologica 94(1): 113–122

    Article  PubMed  Google Scholar 

  8. Cornely OA et al. (2007). Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356: 348–359

    Article  CAS  PubMed  Google Scholar 

  9. Ullmann AJ et al. (2007). Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356: 335–47

    Article  CAS  PubMed  Google Scholar 

  10. Vehreschild JJ et al. (2009) Reduced Incidence of Pneumonia and Invasive Pulmonary Aspergillosis After Introduction of Posaconazole Prophylaxis – Data From the Cologne AML Cohort. Onkologie; 32(Suppl 4). Abstract P691.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brennpunkt Infektiologie. Wien klin Mag 12, 48–51 (2009). https://doi.org/10.1007/s00740-009-0193-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00740-009-0193-7

Search

Navigation